💊 Drugs A-Z 🧬 Targets 🛠 Tools 📚 Guides
All Drugs Drug Classes Therapeutic Areas Side Effects
Guides Glossary Timeline
Comparisons Drug Journeys Drug Families
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Bentoquatam

CHEMBL1201446 Phase 4 Approved Unknown
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
180.1 g/mol
LogP
—
Phase
4

A physical barrier substance applied to the skin to prevent urushiol, the allergenic oil in poison ivy and related plants, from penetrating and causing contact dermatitis. It is the only FDA-approved skin protectant for this purpose.

Molecular Weight

180.0600 g/mol

TPSA

78.50 Ų

Mechanism of Action

Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

2D Structure

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
O.O=[Al]O[Al]=O.O=[Si]=O

                

                

                
                

                    
InChI

                    
InChI=1S/2Al.O2Si.H2O.3O/c;;1-3-2;;;;/h;;;1H2;;;

                

                

                

                    
                    

                        
Molecular Formula

                        
Al2H2O6Si

                    

                    
                    

                        
HBD / HBA

                        
1 / 6

                    

                    
                    

                        
Rotatable Bonds

                        
0

                    

                    
                    
                    

                        
Heavy Atoms

                        
9

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Frequently Asked Questions

                

                    
                    

                        
                        

                            
A physical barrier substance applied to the skin to prevent urushiol, the allergenic oil in poison ivy and related plants, from penetrating and causing contact dermatitis. It is the only FDA-approved skin protectant for this purpose.

                        

                    

                    

                    

                    
                    

                        
                        

                            
Forms an occlusive barrier on the skin surface, reducing transepidermal water loss and protecting the underlying tissue from external irritants.

                        

                    

                    

                    

                    

                        
                        

                            
Yes, Bentoquatam is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1201446.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 517273.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.




        


        
        
    


    



    
Medical Disclaimer

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.